Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) EBT (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed EBT for 3 consecutive years, with -$12.1 million as the latest value for Q4 2025.

  • Quarterly EBT rose 9.13% to -$12.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$50.4 million through Dec 2025, up 2.5% year-over-year, with the annual reading at -$50.6 million for FY2025, 2.35% up from the prior year.
  • EBT hit -$12.1 million in Q4 2025 for Camp4 Therapeutics, up from -$13.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$11.7 million in Q3 2023 to a low of -$13.5 million in Q3 2024.
  • Historically, EBT has averaged -$12.7 million across 3 years, with a median of -$12.5 million in 2025.
  • Biggest five-year swings in EBT: dropped 15.29% in 2024 and later increased 9.13% in 2025.
  • Year by year, EBT stood at -$13.0 million in 2023, then fell by 2.22% to -$13.3 million in 2024, then grew by 9.13% to -$12.1 million in 2025.
  • Business Quant data shows EBT for CAMP at -$12.1 million in Q4 2025, -$13.2 million in Q3 2025, and -$12.6 million in Q2 2025.